LOGIC Education is an educational programme for healthcare professionals that is organised and funded by Tillotts Pharma UK, as part […]
My experience working within the Nightingale North West COVID-19 response hospital Dr Andy Jenkins In March the number of COVID-19 […]
Tillotts Pharma AG has a strong presence in Europe with affiliates and distributors in all major European markets. The UK business is the largest wholly owned affiliate of Switzerland based Tillotts Pharma AG, and part of the Japanese Zeria Group.
Tillotts Pharma UK Ltd was established in March 2010. Jeremy Thorpe (Managing Director) joined in July 2012, with a clear focus on optimising the portfolio of gastrointestinal (GI) health products. Tillotts Pharma UK is now a market leader.
Since its foundation, Tillotts has been committed to improving care for people with gastrointestinal (GI) diseases. We collaborate with healthcare professionals and GI-experts to develop and market medicines for the treatment of diseases of the digestive system.
Our specific focus on the digestive system means we have in-depth knowledge of the challenges that gastroenterologists and hepatologists face on a daily basis. It also helps us look for innovative ways to improve care and quality of life for the 5–6 million people who live with inflammatory bowel diseases worldwide.
At Tillotts Pharma UK, we are a dedicated and passionate group of people. Everything we do is guided by how we can improve the lives of people with GI diseases, and support those who care for them.
We prioritise hiring the right people. The success of the business comes from the relationships we’ve built with our customers, and to do this we need good people.